Back
Corvus Pharmaceuticals Vs. Triumph Financial Industry Stock Comparison
Buy
51
CRVS
Corvus Pharmaceuticals
Last Price:
1.78
Seasonality Move:
16.51%
Sell
48
TFIN
Triumph Financial
Last Price:
75.67
Seasonality Move:
14.47%
Buy
51
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $1.81. The Score for CRVS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Triumph Financial (TFIN)
is a Sell
Is Triumph Financial a Buy, Sell or Hold?
- The current Triumph Financial [TFIN] share price is $77.07. The Score for TFIN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $1.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing slight selling pressure.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $77.07
The current trend is moderately bullish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 39.77 | Sell |
| Chaikin Money Flow: | -28490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.93 - 2.19) | Sell |
| Bollinger Bands (100): | (1.69 - 2.23) | Sell |
TFIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 56.06 | Buy |
| Chaikin Money Flow: | 91022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.94 - 76.64) | Buy |
| Bollinger Bands (100): | (72.35 - 77.47) | Buy |
CRVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.91 | Sell |
| 20-day SMA: | 2.04 | Sell |
| 50-day SMA: | 1.9 | Sell |
| 200-day SMA: | 1.78 | Buy |
| 8-day EMA: | 1.9 | Sell |
| 20-day EMA: | 1.98 | Sell |
| 50-day EMA: | 1.96 | Sell |
| 200-day EMA: | 1.87 | Sell |
TFIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.85 | Buy |
| 20-day SMA: | 74.74 | Buy |
| 50-day SMA: | 73.79 | Buy |
| 200-day SMA: | 71.88 | Buy |
| 8-day EMA: | 76.24 | Buy |
| 20-day EMA: | 75.29 | Buy |
| 50-day EMA: | 74.73 | Buy |
| 200-day EMA: | 71.96 | Buy |
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.07 per share, and a decrease next year of $0.07 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.44 per share, and an increase next year of $1.18 per share.
Corvus Pharmaceuticals Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Triumph Financial Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||